We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
Guillain-Barré syndrome is a rare neurological condition which can occur following Zika virus infection.
The MHRA was alerted by Beyond Compliance and the UK National Joint Registry (NJR) to a significantly higher revision rate observed with the ORIGIN PS patient-matched total knee replacement.
Healthcare professionals prescribing fluoroquinolone antibiotics (ciprofloxacin, delafloxacin, levofloxacin, moxifloxacin, ofloxacin) are reminded to be alert to the risk of disabling and potentially long-lasting or irreversible side effects. Do not prescribe fluoroquinolones for non-severe or self-limiting infections, or for mild to...
You must tell DVLA if you have muscular dystrophy - download the correct form to let them know.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The government’s plans for the NHS and social care to deliver for patients, this winter and next.
Practical advice for clinicians caring for immunocompromised persons who wish to travel or who have travelled to Zika-affected countries or areas.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
New tool uses artificial intelligence to assess hospital data and help predict patients at risk of becoming long stayers, with resulting negative implications.
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the identified risk of disabling and potentially long-lasting or...
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Advice for medical professionals for assessing fitness to drive.
Information for healthcare professionals to protect the public from pressure ulcers (bed sores).
A letter that NHS trusts can send patients who are migrants or overseas visitors to explain that they need to pay for their assisted conception treatment.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.